185 related articles for article (PubMed ID: 30668179)
1. Randomized placebo-controlled clinical trial on efficacy and safety of topical 10% Potassium hydroxide for
Giner-Soriano M; Teixidó C; Marsal JR; Díez O; Pera H; Vlacho B; Morros R;
J Dermatolog Treat; 2019 Dec; 30(8):750-756. PubMed ID: 30668179
[No Abstract] [Full Text] [Related]
2. Efficacy and safety of topical application of 15% and 10% potassium hydroxide for the treatment of Molluscum contagiosum.
Teixidó C; Díez O; Marsal JR; Giner-Soriano M; Pera H; Martinez M; Galindo-Ortego G; Schoenenberger JA; Real J; Cruz I; Morros R
Pediatr Dermatol; 2018 May; 35(3):336-342. PubMed ID: 29479727
[TBL] [Abstract][Full Text] [Related]
3. Comparative study of 5% and 2.5% potassium hydroxide solution for molluscum contagiosum in children.
Uçmak D; Akkurt MZ; Kacar SD; Sula B; Arica M
Cutan Ocul Toxicol; 2014 Mar; 33(1):54-9. PubMed ID: 23713782
[TBL] [Abstract][Full Text] [Related]
4. Treatment of molluscum contagiosum with potassium hydroxide: a clinical approach in 35 children.
Romiti R; Ribeiro AP; Grinblat BM; Rivitti EA; Romiti N
Pediatr Dermatol; 1999; 16(3):228-31. PubMed ID: 10383783
[TBL] [Abstract][Full Text] [Related]
5. The efficacy and safety of topical 10% potassium hydroxide for molluscum contagiosum: a systematic review and meta-analysis.
Heo JY; Park TH; Kim WI
J Dermatolog Treat; 2022 May; 33(3):1682-1690. PubMed ID: 33667150
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and tolerance of the topical application of potassium hydroxide (10% and 15%) in the treatment of molluscum contagiosum: randomized clinical trial: research protocol.
Marsal JR; Cruz I; Teixido C; Diez O; Martinez M; Galindo G; Real J; Schoenenberger JA; Pera H
BMC Infect Dis; 2011 Oct; 11():278. PubMed ID: 22011376
[TBL] [Abstract][Full Text] [Related]
7. An open, nonrandomized, comparative study of imiquimod 5% cream versus 10% potassium hydroxide solution in the treatment of molluscum contagiosum.
Metkar A; Pande S; Khopkar U
Indian J Dermatol Venereol Leprol; 2008; 74(6):614-8. PubMed ID: 19171985
[TBL] [Abstract][Full Text] [Related]
8. Double-blind, randomized, placebo-controlled trial of the use of topical 10% potassium hydroxide solution in the treatment of molluscum contagiosum.
Short KA; Fuller LC; Higgins EM
Pediatr Dermatol; 2006; 23(3):279-81. PubMed ID: 16780480
[TBL] [Abstract][Full Text] [Related]
9. Comparative study of 5 % potassium hydroxide solution versus 0.05% tretinoin cream for Molluscum Contagiosum in children.
Rajouria EA; Amatya A; Karn D
Kathmandu Univ Med J (KUMJ); 2011; 9(36):291-4. PubMed ID: 22710541
[TBL] [Abstract][Full Text] [Related]
10. Potassium hydroxide 5% for the treatment of molluscum contagiosum.
Drug Ther Bull; 2014 Oct; 52(10):118-20. PubMed ID: 25298120
[TBL] [Abstract][Full Text] [Related]
11. An open, comparative study of 10% potassium hydroxide solution versus salicylic and lactic acid combination in the treatment of molluscum contagiosum in children.
Köse O; Özmen İ; Arca E
J Dermatolog Treat; 2013 Aug; 24(4):300-4. PubMed ID: 22214282
[TBL] [Abstract][Full Text] [Related]
12. Treatment of pediatric molluscum contagiosum with 10% potassium hydroxide solution.
Can B; Topaloğlu F; Kavala M; Turkoglu Z; Zindancı I; Sudogan S
J Dermatolog Treat; 2014 Jun; 25(3):246-8. PubMed ID: 22639976
[TBL] [Abstract][Full Text] [Related]
13. Comparison Of Efficacy Of 10% Potassium Hydroxide Solution Versus Cryotherapy In Treatment Of Molluscum Contagiosum.
Qureshi A; Zeb M; Jalal-Ud-Din M; Sheikh ZI; Alam MA; Anwar SA
J Ayub Med Coll Abbottabad; 2016; 28(2):382-385. PubMed ID: 28718569
[TBL] [Abstract][Full Text] [Related]
14. Safety and Efficacy of VP-102, a Proprietary, Drug-Device Combination Product Containing Cantharidin, 0.7% (w/v), in Children and Adults With Molluscum Contagiosum: Two Phase 3 Randomized Clinical Trials.
Eichenfield LF; McFalda W; Brabec B; Siegfried E; Kwong P; McBride M; Rieger J; Willson C; Davidson M; Burnett P
JAMA Dermatol; 2020 Dec; 156(12):1315-1323. PubMed ID: 32965495
[TBL] [Abstract][Full Text] [Related]
15. Comparison of 10% potassium hydroxide solution versus cryotherapy in the treatment of molluscum contagiosum: an open randomized clinical trial.
Handjani F; Behazin E; Sadati MS
J Dermatolog Treat; 2014 Jun; 25(3):249-50. PubMed ID: 23924070
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the effectiveness of 5% potassium hydroxide for the treatment of molluscum contagiosum.
Romiti R; Ribeiro AP; Romiti N
Pediatr Dermatol; 2000; 17(6):495. PubMed ID: 11189099
[No Abstract] [Full Text] [Related]
17. Acute ulceronecrotic adverse reaction to potassium hydroxide 5% solution in the treatment of molluscum contagiosum.
Bresesti I; Ciolfi C; Rotatore G; Borisov AN; Zuccotti GV; Brazzelli V
Pediatr Dermatol; 2020 Jan; 37(1):224-225. PubMed ID: 31625620
[TBL] [Abstract][Full Text] [Related]
18. Interventions for cutaneous molluscum contagiosum.
van der Wouden JC; Menke J; Gajadin S; Koning S; Tasche MJ; van Suijlekom-Smit LW; Berger MY; Butler CC
Cochrane Database Syst Rev; 2006 Apr; (2):CD004767. PubMed ID: 16625612
[TBL] [Abstract][Full Text] [Related]
19. Safety and efficacy of topical cantharidin for the treatment of pediatric molluscum contagiosum: a prospective, randomized, double-blind, placebo-controlled pilot trial.
Guzman AK; Schairer DO; Garelik JL; Cohen SR
Int J Dermatol; 2018 Aug; 57(8):1001-1006. PubMed ID: 29904968
[TBL] [Abstract][Full Text] [Related]
20. Topical Imiquimod is an Effective and Safe Drug for Molluscum Contagiosum in Children.
Badavanis G; Pasmatzi E; Monastirli A; Georgiou S; Tsambaos D
Acta Dermatovenerol Croat; 2017 Jul; 25(2):164-166. PubMed ID: 28871935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
